株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外診断 (IVD) 検査の世界市場:第12版

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition

発行 Kalorama Information 商品コード 909955
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
体外診断 (IVD) 検査の世界市場:第12版 The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition
出版日: 2019年08月02日 ページ情報: 英文
担当者のコメント
IVDのゴールドスタンダード的レポートとして従来は2年毎に更新しており、11th Editionは2018年夏に発行されましたが、今回12th Editionを2019年8月に発行いたしました。12thエディションは2000ページを超えるレポートとなっています。定量的なデータもありますが、定性的情報の充実度が高く、業界や各企業の同行などについて最新の情報が反映されています。
概要

当レポートでは、世界のIVD (体外診断) 検査市場について調査し、市場の概要、セグメント/2次セグメント別による市場規模と予測、および主要地域/国別による市場の分析と予測、ならびに各セグメントにおける主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 世界の体外診断 (IVD) 市場概要

  • 背景
  • 世界の人工・高齢化
  • 疾病負担の推移
  • 新興市場
  • 世界のIVD市場の規模・予測
  • 米国におけるIVD市場
  • 欧州におけるIVD市場:回復が続く
  • 東欧におけるIVD市場:成長地域
  • 日本におけるIVD市場:成長が戻る
  • 中国におけるIVD市場:現在のIVD市場
  • インドにおけるIVD市場:人口と機会
  • その他のアジアにおけるIVD市場
  • ブラジルにおけるIVD市場
  • メキシコにおけるIVD市場
  • ロシアにおけるIVD市場
  • カナダにおけるIVD市場
  • 新興市場
  • IVD市場の機会:国別

第4章 企業・産業動向

  • イントロダクション
  • 遺伝子編集
  • マイクロバイオーム
  • リキッドバイオプシー
  • ITの進歩とAI
  • エキソソームシーケンシング
  • 免疫測定検出エラーにおけるビオチン干渉
  • 外傷性脳損傷とIVD
  • ブロックチェーン
  • 薬物乱用
  • マイクロホスピタルの機会
  • 気候変動と感染症、ほか

第5章 ポイントオブケア (POC) 検査

第6章 コアラボ

第7章 免疫測定法

第8章 分子アッセイ

第9章 血液学

第10章 凝固

第11章 微生物学・ウィルス学

第12章 血液バンクサービス

第13章 組織病理学・細胞診

第14章 企業プロファイル:トップティア

第15章 企業プロファイル:セカンドティア

第16章 企業プロファイル:血液バンク専門企業

第17章 企業プロファイル:凝固専門企業

第18章 企業プロファイル:コアラボ・その他企業

第19章 企業プロファイル:CTC & リキッドバイオプシー検査プロバイダー

第20章 糖尿病専門企業

第21章 企業プロファイル:血液学 (細胞分析) 専門企業

第22章 企業プロファイル:組織病理学専門企業

第23章 企業プロファイル:免疫測定専門企業

第24章 IVD (体外診断) における情報技術専門企業

第25章 企業プロファイル:微生物学専門企業

第26章 企業プロファイル:分子検査専門企業

第27章 企業プロファイル:POC検査専門企業

第28章 企業プロファイル:出生前診断専門企業

第29章 品質管理 & サンプル調製専門企業

第30章 検査サービスプロバイダー

目次
Product Code: 19-050

Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. The 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market.

  • 2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities
  • Authored by Veteran IVD Analysts with Industry Knowledge
  • 12 Detailed Market Chapters with 2019 Market Estimate
  • Where is IVD Heading? - Market Segment Projections to 2024
  • Regional Breakouts Including Country IVD Markets
  • Sections on China and The United States IVD Markets
  • Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
  • Used by Major IVD Firms for Business Planning
  • Coverage of Trends and Market Estimates for Essential IVD Segments: Clinical Chemistry, Point-of-Care, Molecular, Infectious Disease, Histology and More.

The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2024 for defined segments of the IVD market and various sub-segments, including:

  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal)
  • Clinical Chemistry and "Core Lab" Markets
  • Point-of-Care Testing (POC) (Professional and Self-Testing
  • Glucose Testing
  • Substance Abuse Testing
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking
  • Pap, ISH, IHC, HPV and Other Tissue-Based Tests
  • Infectious Disease Immunoassay Testing
  • Hematology
  • Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
  • Coagulation Tests
  • Direct-to-Consumer Testing

For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2024 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends. The Worldwide Market for In Vitro Diagnostic Tests has been called "The Bible of the IVD Industry" by customers, which include top IVD firms. Using Kalorama Information's The Worldwide Market for In vitro Diagnostic (IVD) Tests, 12th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

Global Coverage for a Global Industry

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:

  • US
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Netherlands
  • Turkey
  • Poland
  • Canada
  • China
  • Japan
  • Saudi Arabia
  • Brazil
  • Eastern Europe
  • Emerging Markets
  • Rest of World

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2019.

Who's In The Market? Who's Winning?

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.

  • Abbott Diagnostics
  • Arkray
  • Becton, Dickinson
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad
  • Danaher
  • DiaSorin
  • Grifols
  • Hologic
  • Instrumentation Laboratory
  • Qiagen
  • Radiometer
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Werfen
  • And others...

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: The Worldwide IVD Market, 2019-2024 ($millions)
  • SCOPE AND METHODOLOGY
    • Table 1-1: Exchange Rate Fluctuations, 2014-2018
  • FINDING WHAT YOU ARE LOOKING FOR IN THE 12TH EDITION
    • Table 1-2: Finding What You Are Looking For in the 12th Edition
  • SIZE AND GROWTH OF THE MARKET
    • Table 1-3: Global In Vitro Diagnostic Sales by Product Market, 2019-2024 ($ million)
    • Figure 1-2: Regional Distribution of IVD Market, 2019
  • IVD MARKET HIGHLIGHTS
  • COMPETITIVE PICTURE IN IVD
  • WHAT TO WATCH
    • China and Top Emerging Nations Markets
    • Next-Generation Sequencing and IVD
    • Direct-to-Consumer
    • Gene Editing
    • Liquid Biopsy
    • Information Technology and AI
    • New Venues - Urgent & Retail Care, "Microhospitals"

TWO: INTRODUCTION

  • IVD LANDSCAPE
  • REPORT DESIGN
  • THE CHALLENGE OF PAMA
  • MARKET ANALYSIS OF IVD MARKET SEGMENTS
    • Table 2-1: Global In Vitro Diagnostic Sales by Product Market, 2019-2024 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry)
  • TOP SUPPLIERS AND NICHE PLAYERS
    • Introduction
    • Overview of the Top Tier Companies
    • Table 2-2: Revenues of Selected Top IVD Companies, 2014-2018 ($ million, estimated)
    • Overview of Selected Second Tier Companies
    • Table 2-3: Revenues of Selected Niche Players, 2014-2018 ($ million, estimated)
  • IVD COMPANIES MERGERS & ACQUISITIONS
    • Table 2-4: Selected IVD Mergers and Acquisitions late 2018 to mid-2019
  • MARKET EXPANSION INITIATIVES
    • Table 2-5: Selected Market Expansion Initiatives, 2018 & H1 2019
  • DISTRIBUTION AGREEMENTS
    • Table 2-6: Selected Diagnostics Industry Distribution Agreements, 2016, 2017, 2018, 2019
  • LICENSES AND COLLABORATION AGREEMENTS
    • Table 2-7: Selected IVD Partnerships/Collaborations/Licensing Agreements, 2016, 2017, 2018, 2019
  • TEST SERVICES
    • Table 2-8: Selected Test Services, Sales 2013-2018 ($ millions, estimated where applicable)
    • Table 2-9: Global Lab Market Segmentation, 2018 ($ billions) (Hospital Labs, Independent Labs, Physician
    • Office Labs)
    • Table 2-10: Revenues for a Selection of U.S.-based Reference Labs, 2013-2018 ($ million, estimated) ..99
  • HISTORICAL IVD MARKET VS TODAY
    • In the Beginning to Now
    • Figure 2-1: Share of IVD Market by Segment, Percentage, 2000 and 2019 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays, Microbiology (ID/AST), POC Diabetes, POC - Other, Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
    • Future
  • POINT OF VIEW

THREE: THE GLOBAL PICTURE FOR IN VITRO DIAGNOSTIC MARKETS

  • BACKGROUND
    • Simultaneous Threats: Chronic and Acute
    • Expected World IVD Market Developments
  • GLOBAL POPULATION AND AGING
    • Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
    • Workforce Reduction
    • Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World)
    • Addressing the Aging Trend
  • SHIFTING DISEASE BURDENS
    • Table 3-3: Changing DALY ranking of Disease Threats (disability-adjusted life year) Worldwide (HIV/AIDS, Malaria, Lung Cancer, TB, Neonatal Preterm Birth, Asthma, Heart Disease, Depression, Stroke, Cerebral Hemorrhage, Low Back Pain, Alzheimer's, COPD)
    • Increase in Chronic Diseases
  • EMERGING AND EMERGED MARKETS
    • Table 3-4: Available Market Data, 2018 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)
    • Emerging Nations and Health Insurance
  • SIZE AND FORECAST FOR THE GLOBAL IVD MARKET
    • Table 3-5: Global In Vitro Diagnostic Market; Major Country/Region Markets, 2019 and 2024 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, India, Eastern Europe, Brazil, Colombia, Mexico,
    • Saudi Arabia, Turkey, UAE, Malaysia, Russia, South Africa, South Korea, Australia, ROW)
    • Regional Reporting Differences with the 11th Edition
  • THE IVD MARKET IN THE UNITED STATES
    • Table 3-6: United States IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST,
    • Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other,
    • Clinical Sequencing, Nucleic Acid Assays, Coagulation, Histology, Hematology, Blood Grouping, Others) . 124
    • PAMA and Reimbursement Changes
    • LDT Oversight Update
    • Rare Disease Testing
    • Personalized Medicine and NGS
  • IVD MARKET IN EUROPE: CONTINUED RECOVERY
    • Figure 3-1: Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Austria, Belgium,
    • Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden,
    • Switzerland, United Kingdom)
    • Europe Industry Actions
    • Table 3-7: Western European IVD Market by Country, 2019 ($ millions, estimated) (Austria, Belgium,
    • Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden,
    • Switzerland/Norway, UK)
    • EU Regulation
    • Table 3-8: IVD Market Per Capita, Europe, 2018 Estimates (Switzerland, Germany, Netherlands, Sweden,
    • France, Slovenia, United Kingdom, Italy, Spain, Slovakia, Greece, Croatia, Lithuania, Czech Republic,
    • Hungary, Poland, Romania, Serbia, Bulgaria, Russia, Ukraine)
    • Personalized Medicine in Europe
    • Brexit
    • Austerity
  • EASTERN EUROPE: GROWTH REGION
    • Figure 3-2: Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Czech Republic,
    • Estonia, Hungary, Latvia, Lithuania, Poland, Slovak Republic, Slovenia)
    • Table 3-9: Eastern European IVD Market by Country, 2019 ($ millions) (Bulgaria, Croatia, Czech Republic,
    • Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
    • Figure 3-3: Eastern Europe IVD Market by Country - Segment Distribution, 2019 ($ millions) (Bulgaria,
    • Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
  • JAPAN: RETURN TO GROWTH
    • Table 3-10: Japan IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology
    • Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation,
    • Histology, Hematology, Others)
  • CHINA: CURRENT IVD MARKET
    • Table 3-11: China IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology
    • Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation,
    • Histology, Hematology, Others)
    • Table 3-12: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
    • Clinical Laboratory Tests in China
    • Figure 3-4: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015 (General
    • Hospitals, Specialized Hospitals, Chinese Medical Hospitals, Community Health Service Centers, Health
    • Centers [Urban and Township], Village Clinics, Others)
    • Private Laboratories
    • Distribution in China
  • INDIA: POPULATION AND OPPORTUNITY
    • Table 3-13: India IVD Market by Segment, 2019 (%) (Clinical Chemistry, Hematology, Coagulation;
    • Microbiology; POC Diabetes; POC Other; Immunoassay; Histology; Others)
    • Labs in India
  • REST OF ASIA
    • Table 3-14: Asia Pacific IVD Market by Country, 2019 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
  • BRAZIL
    • Disease Trends
    • Table 3-15: Brazil IVD Market by Segment, 2019 (%)
  • MEXICO
    • Table 3-16: Mexico IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
  • THE RUSSIAN FEDERATION
  • CANADA
  • EMERGING MARKETS
    • Saudi Arabia IVD Market
    • South Africa IVD Market
    • Turkey IVD Market
    • Colombia IVD Market
    • United Arab Emirates (UAE) IVD Market
    • South Korea IVD Market
    • Other Markets to Watch
    • IVD MARKET OPPORTUNITY BY COUNTRY
    • Table 3-17: IVD Market Opportunity by Country (2019 Market Rank, 2018 Market Rank, Country CAGR 2019-2024) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)

FOUR: COMPANY AND INDUSTRY TRENDS

  • INTRODUCTION
    • Advanced Medicine Without Borders
    • China Market Information
    • IVD Company Initiatives in China
    • Table 4-1: Selected IVD Initiatives in China
    • Clinical Genetic Test Advances
    • Direct to Consumer Genetic Test Services
    • Programs and Initiatives
    • Table 4-2: Selected Genomic Test Innovations
    • Future Trends
  • GENE EDITING
    • Table 4-3: Selected Gene Editing / CRISPR Innovations
    • CRISPR as a Diagnostic Tool
    • Basic Research
    • Food Industry
    • Investor Interest
  • MICROBIOME
    • Table 4-4: Selected Microbiome Test Innovations
  • LIQUID BIOPSY
    • Table 4-5: Liquid Biopsy: Selected Liquid Biopsy Innovations
    • Quality Assurance
    • Product News
    • Market Cleared Products
    • For Research Use Only
    • Products in Development
    • Liquid Biopsy in Microbiology
    • The Future for Liquid Biopsy
  • INFORMATION TECHNOLOGY ADVANCES AND ARTIFICIAL INTELLIGENCE
    • AI in Clinical Practice
    • Table 4-6: Selected AI Market Cleared Tests
    • The Regulatory Pathway
    • Product Initiatives
    • Table 4-7: Selected AI Product Initiatives in Development and Collaborations
    • IBM Watson Health
    • AI in Liquid Biopsy
    • Table 4-8: Selected AI/Liquid Biopsy Initiatives
    • Future Trends
  • EXOSOME SEQUENCING
    • Table 4-9: Selected Exosome Test Innovations
    • BIOTIN INTERFERENCE IN IMMUNOASSAY DETECTION ERRORS
    • Table 4-10: Biotin-free Offerings Currently on the Market
  • TRAUMATIC BRAIN INJURY AND IVD
  • BLOCKCHAIN
  • SUBSTANCE ABUSE
    • Opioid Epidemic
    • Biomarkers and Substance Abuse
    • Clinical Laboratory Testing for Drugs of Abuse
    • Table 4-11: Global Drug Abuse Statistics
    • Urine
    • Blood
    • Oral
    • Hair
    • Table 4-12: Selected Opioid FDA Approvals, 2015-2019
  • MICRO-HOSPITAL OPPORTUNITIES
  • CLIMATE CHANGE AND INFECTIOUS DISEASE
  • KICKBACK SCHEMES
  • EARLY SEPSIS DETECTION

FIVE: POINT-OF-CARE TESTS

  • OVERVIEW AND TRENDS
  • PROFESSIONAL POC
    • Table 5-1 Professional POC Test Sales by Category, Worldwide 2019 -2024 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
    • Table 5-2: Selected Profession POC Test Innovations
  • OTC SELF TESTING
    • Table 5-3: POC Self-Test Sales by Category, Worldwide, 2019-2024 ($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc])
  • PREGNANCY/FERTILITY TESTS
    • Table 5-4: POC Pregnancy and Fertility Test Market Distribution by End User, 2019 (%) (OTC, PRO) .
    • Table 5-5: Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
  • COLON CANCER SCREENING
    • Table 5-6: Colon Cancer POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • LIPID TESTING
    • Table 5-7: Lipid POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW) 289
  • POC INFECTIOUS DISEASE TESTING
    • Table 5-8: Innovations in Molecular POC Infectious Disease Diagnostics
    • Products
    • HIV and Hepatitis Testing and Monitoring
    • Tuberculosis
    • Tropical and Neglected Diseases
    • Respiratory Diseases
    • Sepsis and Nosocomial Disease
    • Sexual Health
    • Lyme Disease
    • Table 5-9: Innovations in Molecular POC Infectious Disease Diagnostics
    • Market Size and Growth
    • Table 5-10: Infectious Disease POC Test Demand by Type, 2019 (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
    • Table 5-11: Infectious Disease POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
  • DIABETES TESTING - BLOOD GLUCOSE MONITORING
    • Glucose Testing in Tight Economics
    • Table 5-12: Glucose POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • Figure 5-1: POC Glucose Testing Market Growth by Category, 2019-2024 CAGR (%) (Glucose OTC; Glucose Professional; Glucose, continuous; HbA1c POC)
    • IT to Aid Diabetes Management
    • Table 5-13: Selected Apps and Glucose Management IT
    • Diabetes Market Analysis
    • Table 5-14: Global Diabetes Sales by Test Category, 2019-2024 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
    • Table 5-15: POC Test Revenues of Selected IVD Glucose Companies, 2019 ($ million, estimated)
    • Blood Glucose Self-Testing
    • Table 5-16: Selected Glucose Self-Test Meter Innovations
    • Noninvasive Testing Devices
    • Table 5-17: Selected Noninvasive Glucose Monitoring Devices
    • Continuous Self Testing en Route to the Artificial Pancreas
    • Table 5-18: Selected Continuous Blood Glucose System Developments
    • Blood Glucose Testing by Professionals
    • Table 5-19: Selected Innovations in Hospital-based Glucose Monitoring
    • Diabetes Testing - Glycated Hemoglobin
    • The Worldwide Market for In Vitro Diagnostic Tests, 12th Edition POC, HbA1c Lab)
    • Table 5-21: Selected POC HbA1c Devices
    • Genes and Other Markers of Diabetes
    • Table 5-22: Selected POC Diabetes Monitoring Tests
    • DRUGS OF ABUSE TESTING
    • Table 5-23: POC Drugs of Abuse Test Sales Distribution by Setting, 2019 (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
    • Products
    • Table 5-24: Drugs of Abuse Tests on the Market
    • THE MAJOR POC TEST PLAYERS
    • Table 5-25: POC Test Revenues of Selected IVD Companies (excluding glucose), 2018-2019 ($ million, estimated)

SIX: THE CORE LAB

  • CORE LAB OVERVIEW AND TRENDS
    • Table 6-1: Workstation Sales, 2019-2024 (General Chemistries, Immunoassays on workstations; $ millions)
    • Table 6-2: Workstation Sales (General Chemistries, Immunos on Workstations) of the Top Five Manufacturers, 2018-2019 ($ millions, estimated)
    • Table 6-3: Selected New Analytes for the Core Lab, 2016-2019
  • CONNECTIVITY
  • OVERVIEW OF CHEMISTRY TESTS
    • Lab Automation
    • Service Plans
  • MARKET ANALYSIS
    • Table 6-4: Global Clinical Chemistry Sales by Test Category, 2019-2024 ($millions) (General Chemistries, Blood Gases, Urinalysis)
    • Table 6-5: Global Clinical Chemistry Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 6-6: Major Clinical Chemistry Companies
    • Table 6-7: Selected Clinical Chemistry Innovations
    • Rapid Response Systems
    • Table 6-8: Major Whole Blood Chemistry Analyzers
    • Critical Care Analysis
    • Table 6-9: Blood Gas, Electrolyte and Critical Care Instrument Market by End User, 2019 and 2024 (Labbased, POC-based)
    • Table 6-10: Blood Gas, Electrolyte, and Critical Care Market Leaders, 2019 (percent distribution of total sales)
    • User Apps
    • Table 6-11: Selected Apps, Critical Care and Urinalysis IT Innovations
    • Urinalysis
    • Table 6-12: UA Market by End User, 2019 and 2024 (Lab-based, POC-based)
    • Table 6-13: Urinalysis Systems Market Leaders, 2019 (percent distribution of total sales)
    • Table 6-14: Selected Urinalysis Innovations
    • SLEEP APNEA TESTING: CORE LAB SOLUTION?
  • THE COMMERCIAL OUTLOOK FOR CHEMISTRY TESTS

SEVEN: IMMUNOASSAYS

  • OVERVIEW AND TRENDS
    • Immunoassay Technology Continues to Evolve
    • Table 7-1: Selected Immunoassay Technologies 2019
    • Mass Spectrometry
    • Table 7-2: Selected Innovation in Mass Spectrometry for Routine Analyses
    • Immunoassays in the Core Lab
    • Figure 7-1: Workstation (General Chemistries, Immunos on Workstations) Sales Growth, CAGR 2019-2024
    • Table 7-3: Selected Immunoassay Innovations on Core Lab Instruments
    • Radioimmunoassays
  • MARKET ANALYSIS
    • Leading Suppliers and Growth Potential
    • Table 7-4 Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2019-2024 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
    • Table 7-5: Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 7-6: Selected Immunoassay Quality Control Products
    • Table 7-7: 2019 Revenue of Leading Immunoassay Vendors (in millions $), Estimated
  • MATURE ASSAY SEGMENT
    • Thyroid Function
    • Therapeutic Drug Monitoring
    • Anemia
    • Toxicology/DAU
    • Allergy
  • MATURING IMMUNOASSAYS
    • Proteins
  • GROWTH IMMUNOASSAYS
    • Vitamin D
    • Table 7-8: Selected Vitamin D Immunoassays
    • Tumor Markers
    • Table 7-9: Selected Tumor Marker Innovations
    • Cardiac Markers
    • Table 7-10: Selected Cardiac Marker Innovations
    • Autoimmune
    • Table 7-11: Selected Autoimmune Test Innovations
    • Rheumatoid Arthritis
    • Table 7-12: Selected Arthritis Immunoassay Innovations
    • Gastrointestinal Disorders
    • Table 7-13: Selected Inflammatory Bowel Disease Test Innovations
    • Transplant Management
    • Table 7-14: Selected Immunoassays for Transplant Medicine
    • Women's Health
    • Table 7-15: Selected Women's Health Innovations
    • Alzheimer's Disease
    • Table 7-16: Selected Innovations for Alzheimer's Disease Immunoassays
    • Sleep Apnea
    • Miscellaneous
    • Table 7-17: Selected Immunoassay Innovations
    • Point-of-Care OTC and Professional Use
    • Table 7-18: Global POC Immunoassay Sales Distribution by Region, 2019 (United States, Europe, Japan, RoW)
    • Table 7-19: Global POC Immunoassay Test Sales by Test Category, 2019-2024 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Other, OTC/Self Total; Professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other, Professional Total)
    • Table 7-20: Selected Self-Test Immunoassay Innovations
    • Cardiovascular Diagnostics
    • Drugs of Abuse/Therapeutic Drug Monitoring
  • INNOVATING POC
    • Table 7-21: Selected POC Test Innovations
    • Table 7-22: Selected POC Immunoassay Test Platforms
  • THE COMMERCIAL OUTLOOK FOR IMMUNOASSAYS

EIGHT: MOLECULAR ASSAYS

  • OVERVIEW
    • Table 8-1: Common Next Generation Molecular Test Traits
  • SAMPLE PREPARATION AND QUALITY CONTROL
    • Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
  • ADVANCED MOLECULAR TESTS AND TECHNOLOGIES
    • Exosome Sequencing
    • Table 8-3: Selected Exosome Test Innovations
    • Liquid Biopsy
    • Table 8-4: Selected Liquid Biopsy Innovations
    • Metabolomic Profiling
    • Information Technology for Test Value
    • Table 8-5: Selected IT Innovations in Molecular Diagnostics
    • Forensic Studies - An Emerging Opportunity
    • Table 8-6: Selected Innovations in Forensic DNA Testing
    • Test Platforms
    • Table 8-7: Key Molecular Technologies and Major Players
    • Table 8-8: Selected Molecular Test Platform Innovations
  • MAJOR PLAYERS
    • Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2016-2019 (in millions $)
  • MARKET ANALYSIS
    • Table 8-10: Global Molecular Test Sales by Type 2019-2024 (in millions $) (Oncology, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
    • Oncology
    • Table 8-11: Global Molecular Cancer Test Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Pharmacodiagnostics
    • Table 8-12: Global Pharmacodiagnostic Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 8-13: Selected Molecular Tumor Marker Test Innovations
    • Inherited Diseases and Thrombophilia SNPs
    • Table 8-14: Most Frequently Requested Genetic Tests
    • Table 8-15: Global Molecular Thrombophilia Assay Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 8-16: Selected Genomic Tests for Inherited Diseases
    • Psychiatric Disorders
    • Prenatal and Newborn Testing
    • Table 8-17: Global Prenatal Test Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 8-18: Prenatal Services Provided
    • Table 8-19: Selected Molecular Tests for Prenatal Analysis
    • Tissue Typing
    • Table 8-20: Global Molecular HLA Testing Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 8-21: Selected HLA Typing Test Innovations
  • THE COMMERCIAL OUTLOOK FOR MOLECULAR TESTS

NINE: HEMATOLOGY

  • OVERVIEW OF HEMATOLOGY AND TRENDS
    • Digital Image Analysis
    • Table 9-1: CellaVision Market Share Data by Hematology Vendor 2019
    • Table 9-2: Selected Hematology Image Analysis Innovations, 2014-2019
    • Digital Evolution
    • Quality Control Measurement Programs
  • LABORATORY-BASED HEMATOLOGY TESTING
    • Table 9-3: Selected Hematology Innovations, 2014-2019
    • Table 9-4: Global Laboratory-based Hematology Test and Instrument Market, 2019 and 2024 ($ millions)
    • Regional Laboratory-based Hematology Test and Instrument Market
    • Table 9-5: Global Laboratory-based Hematology Test and Instrument Market, by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • DECENTRALIZED HEMATOLOGY TESTING
    • Hemoglobin/Hematocrit at the POC
    • Table 9-6: Selected POC Hemoglobin and Hematocrit Systems
    • Table 9-7: Decentralized Hematology Test and Instrument Market, 2019 and 2024 ($ millions) (Instruments, lab-style; Handheld devices)
  • MARKET ANALYSIS: LEADING SUPPLIERS
    • Table 9-8: Top Hematology, including d-dimer, Company Revenues (laboratory and POC), 2019 ($ millions)
    • Table 9-9: Global Hematology (Laboratory-based and POC) Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • THE COMMERCIAL OUTLOOK FOR HEMATOLOGY TESTS

TEN: COAGULATION

  • OVERVIEW AND TRENDS OF COAGULATION AND IMMUNOHEMATOLOGY TESTS
  • SPECIAL TOPICS
    • Direct Oral Anticoagulants (DOACs)
    • D-dimer
    • Table 10-1: Global D-dimer Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • MARKET ANALYSIS
    • Table 10-2: Global Coagulation Sales by Segment, 2019-2024 ($millions) (PT/INR Labs, Molecular, Professional POC, Professional Self; D-dimer)
    • Table 10-3: Global Coagulation Test and Instrument Market by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • LAB-BASED TESTING
    • Table 10-4: Selected Lab-based Coagulation Innovations
    • Genetic Markers of Hypercoagulopathies
    • Table 10-5: Global Molecular - Thrombophilia SNP Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Table 10-6: Selected Molecular Coagulation Test Innovations
  • LEADING SUPPLIERS: LABORATORY SYSTEMS
    • Table 10-7: Top Coagulation Company Revenues, Laboratory-based - 2019 ($ millions)
  • DECENTRALIZED COAGULATION TESTING - PROFESSIONAL USE
    • Decentralized Coagulation Testing - OTC
    • Table 10-8: Selected POC Coagulation Test Innovations
    • Platelet Testing
    • Table 10-9: Selected Platelet Activity Test Innovations
  • LEADING SUPPLIERS: POC SYSTEMS
    • Table 10-10: Top Coagulation Company Revenues, POC - 2019 ($ millions)
  • THE COMMERCIAL MARKET FOR COAGULATION TESTS
    • Table 10-11: Major Anticoagulants Uses and Tests

ELEVEN: MICROBIOLOGY AND VIROLOGY

  • IMPORTANT STATISTICS
    • Table 11-1: The Top Ten Leading Causes of Death
  • THE REAL IMPACT OF INFECTIONS
    • Herpes and Alzheimer's Disease
    • Ebola and Cancer
    • HIV and Cancer
    • H pylori and Cancer
    • Bacteria and Parkinson's
  • MICROBIAL ANTIBIOTIC RESISTANCE - THE ROLE OF CLINICAL TESTS
    • "Faster Identification: Where Are We?"
    • Table 11-2: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
  • TRADITIONAL MICROBIOLOGY AND ITS LIMITS
  • THE NEW MICROBIOLOGY - INNOVATIONS
    • Liquid Based Microbiology and Automation Innovations
    • Post-Blood Culture Microbial ID
    • PCR and Other NAAT-Based Tests for Infectious Diseases
    • Table 11-3: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology.667
    • Microbiome-Related Microbiology Tests
    • Table 11-4: Selected Microbiome-Based Tests
    • Next Generation Sequencing-Based Microbiology Approaches
    • Table 11-5: Selected Companies Applying DNA/RNA Sequencing to Microbiology
    • Syndromic Testing
  • NEW INFECTIOUS DISEASE THREATS
    • Table 11-6: Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats .688
    • Tickborne Diseases (TBDs)
    • Zika
    • Chagas
    • Dengue
    • Ebola
    • Chikungunya
    • Next Threats?
  • MICROBIOLOGY FIRMS ACQUISITIONS AND COLLABORATIONS
  • MARKET ANALYSIS
    • Table 11-7: Global Microbiology Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • MARKET ANALYSIS - TRADITIONAL MICROBIOLOGY ID/AST
    • Table 11-8: Global Microbiology ID/AST Market, 2019-2024 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
    • Table 11-9: Global ID/AST Testing Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Traditional ID/AST
    • Table 11-10: Global ID/AST Testing, Distribution by Systems, 2019 (%) (Panel, Auto)
    • Blood Culture
    • Table 11-11: Selected Advanced Techniques in Positive Blood Culture
    • Chromogenic Media
    • Rapid Tests Performed on Colonies from Culture Media
    • Supplies
  • MARKET ANALYSIS - MICROBIOLOGY IMMUNOASSAYS
    • Improvements in Microbiology Immunoassays
    • Table 11-12: Selected Infectious Disease Immunoassay Innovations
    • Table 11-13: Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2019 (in $ millions) (Hepatitis, HIV, STDs, TORCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other)
    • Table 11-14: Global Clinical Chemistry Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Hepatitis Testing
    • Sepsis
    • HIV Immunoassay Testing
    • Table 11-15: Selected HIV Assays
    • Sexually Transmitted Diseases (STDs)
    • TORCH
    • Lyme Disease
    • Rapid Immunoassay Tests
    • Table 11-16: Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2019 (%) (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
  • MARKET ANALYSIS - MOLECULAR MICROBIOLOGY
    • Table 11-17: Global Molecular Microbiology Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 11-18: Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2019-2024 (in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
    • Molecular Respiratory Infection Testing
    • Table 11-19: Selected Molecular Point of Care Innovations in Microbiology
    • Molecular Testing for Sexually Transmitted Diseases
    • Molecular Hepatitis Testing
    • Molecular HIV Testing
    • Table 11-20: Innovations in Molecular POC Diagnostics for HIV
    • Molecular Tests for Hospital-Acquired Infections (HAIs)
    • Table 11-21: Frequency of the Most Common Nosocomial Infections
    • Clostridium Difficile
  • MRSA
    • Molecular TB Testing
    • Limitations of Molecular Microbiology Testing
  • MASS SPECTROMETRY
    • Table 11-22: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
  • THE FUTURE OUTLOOK FOR MICROBIOLOGY

TWELVE: BLOOD BANKING SERVICES

  • OVERVIEW
    • Table 12-1: History of Blood Testing
    • THE CURRENT STATUS OF GLOBAL BLOOD COLLECTION
    • Table 12-2: Distribution of Blood Units Collected, 2011-2013 (United States, United Kingdom, India, Japan, China, Canada, ROW, World Total)
  • GLOBAL BLOOD SAFETY
    • Table 12-3: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
    • Table 12-4: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group ..785
    • Zika Virus
  • BLOOD AND COMPONENT COLLECTION
    • Table 12-5: Blood Component Usage for Selected Conditions
    • Table 12-6: Red Blood Cell and Platelet Use by Hospital Services (%)
  • REEVALUATING BLOOD TRANSFUSIONS
    • Table 12-7: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies) 790
  • BLOOD TYPING AND GROUPING MARKET
    • Manual Blood Typing Methods
    • Automated Blood Typing and Screening Methods
    • Molecular Methods
    • Reducing Blood Typing Errors
    • Table 12-8: Selected Blood Typing and Grouping Innovations
    • Size and Growth of Typing Markets
    • Table 12-9: Global Blood Typing Market, 2019-2024 (Typing) (in $ millions)
    • Blood Typing Market by Geography
    • Table 12-10: Global Blood Typing Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
  • BLOOD TESTING MARKET
    • Table 12-11: Selected Blood Testing Innovations
    • Preventing Bacterial Infections
    • Immunoassays
    • Nucleic Acid Testing (NAT)
    • Size and Growth of the Market
    • Table 12-12: Global Blood Banking Diagnostics Market, 2019-2024 (Immunoassay Screen, NAT Screens) (in $ millions)
    • Blood Testing Market by Geography
    • Table 12-13: Global Blood Testing Market by Geography, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 12-14: Global Blood Testing Market by Country, 2019 (%) (United States, Canada, Germany, United Kingdom, France, Japan, China, Latin America)
  • THE COMMERCIAL OUTLOOK FOR BLOOD BANKING TESTING

THIRTEEN: HISTOLOGY AND CYTOLOGY

  • OVERVIEW
  • SPECIAL TOPICS
    • Histology Automation
    • Table 13-1: Selected Histology Lab Automation
    • Table 13-2: Histology Information Technology Tools
    • Advanced Analysis Solutions
    • Table 13-3: Selected Advanced Histology Techniques
    • HPV Goes Core Lab
    • Table 13-4: Global HPV Test Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 13-5: Selected HPV Test Innovations
  • MARKET ANALYSIS
    • Table 13-6: Global Histology/Cytology Sales by Type, 2019-2024 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL; Digital Imaging, CTCs, Flow Cytometry)
    • Histology/Cytology
    • Table 13-7: Global Histology/Cytology Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 13-8: Revenues of the Major Histology Companies, 2016-2019 ($ millions, estimated)
    • Table 13-9: Selected Vendors of Traditional Histology Stains
    • Immunohistochemistry and In Situ Hybridization
    • Table 13-10: Selected In Situ Hybridization-based Tests
    • Table 13-11: Selected IHC Test Innovations
    • Pharmacodiagnostic Histology
    • Table 13-12: Major Pharmacodiagnostic Markers
    • Table 13-13: Selected Pharmacodiagnostic Histology Tests
    • Digital Imaging and Computational Pathology
    • Table 13-14: Selected Digital Imaging Innovations
    • Circulating Tumor Cells
    • Table 13-15: Selected Innovations in CTC Technology
    • Flow Cytometry
  • THE COMMERCIAL OUTLOOK FOR HISTOLOGY AND CYTOLOGY TESTS

FOURTEEN: COMPANY PROFILES: THE TOP TIER

  • ABBOTT DIAGNOSTICS
    • Key Comment
    • Recent Revenue History
    • Alere Acquisition Update and Point of Care
    • Core Lab
    • Hematology
    • Blood Banking
    • Coagulation
    • Infectious Diseases - Molecular
    • Diabetes
    • HIV Point of Care
    • i-STAT Business
    • Companion Testing
    • Liquid Biopsy
  • ARKRAY
    • Key Comment
    • Dry Chemistry / Immunoassays
    • Urinalysis
    • Diabetes
    • Molecular
  • BECTON, DICKINSON AND COMPANY (BD)
    • Key Comment
    • Recent Revenue History
    • Cytology
    • Molecular Microbiology
    • Traditional Microbiology - ID/AST
    • Blood Culture
    • Hospital Acquired Infections
    • Connectivity
    • Blood Collection
    • Mass Spectrometry
    • Flow Cytometry
    • Licensing
  • BECKMAN COULTER, INC. / DANAHER
    • Key Comment
    • Recent Revenue History
    • Hematology
    • Hematology IT
    • Clinical Chemistry
    • Immunoassays
    • Coagulation
    • Microbiology
    • Urinalysis
    • Clinical Information Technology
    • Molecular Tissue Analysis
    • Flow Cytometry
    • A Fight for Brain Natriuretic Peptide (BNP) Assay Rights
    • Beckman Coulter Life Sciences
    • Collaborations
  • BIOMÉRIEUX INC.
    • Key Comment
    • Recent Revenue History
    • Traditional Microbiology
    • Blood Culture
    • Immunoassays
    • Mass Spectrometry
    • Data Analysis
    • BioFire Diagnostics Business
    • Food Testing
    • Expansion
  • BIO-RAD LABORATORIES, INC
    • Key Comment
    • Recent Revenue History
    • Company Highlights in 2017 and 2018
    • Quality Control
    • Blood Bank
    • Diabetes
    • Immunoassays
    • Autoimmune Testing
    • Liquid Biopsy
    • Microbiome
    • Droplet Digital PCR
    • Sequencing
  • DANAHER CORPORATION
    • Key Comment
    • Recent Revenue History
    • For 2018 vs 2017, Danaher Reported . . .
    • Acquisitions
  • DIASORIN S.P.A
    • Key Comment
    • Recent Revenue History
    • Development Plan
    • Expansion
    • Immunoassays
    • Zika Testing
    • Molecular
    • Molecular Oncology
  • GRIFOLS S.A.
    • Key Comment
    • Recent Revenue History
    • Blood Transfusion Business
    • ABO Blood Typing
    • Molecular ABO Blood Typing
    • Immunoassays
    • Coagulation
    • Market Expansion
  • HOLOGIC, INC.
    • Key Comment
    • Recent Revenue History
    • Hologic Global Access Initiative
    • PANTHER Molecular System
    • HIV Testing
    • Sexually Transmitted Infections
    • Infectious Diseases
    • Panther Fusion
    • Cytology
  • INSTRUMENTATION LABORATORY (IL) / WERFEN
    • Key Comment
    • Recent Revenue History
    • 2018 Product Highlights
    • Expansion
    • Coagulation
    • Acute Care
    • Information Technology
  • ORTHO CLINICAL DIAGNOSTICS (ORTHO)
    • Key Comment
    • Recent Revenue History
    • Blood Bank
    • Core Lab / Immunoassays
    • Lab Automation
    • Connectivity
    • Expansion
  • QIAGEN N.V.
    • Key Comment
    • Recent Revenue History
    • Tuberculosis
    • Molecular Expansion
    • Precision Medicine / Companion Diagnostics
    • Molecular Microbiology
    • Prenatal Testing
    • Next Generation Sequencing
    • Sample Prep, Informatics
    • Digital PCR
    • Bioinformatics
    • Liquid Biopsy
    • Microbiome
    • Cervical Cancer
    • Transplant Medicine
    • Forensic
    • Expansion
  • RADIOMETER A/S / DANAHER
    • Key Comment
    • Recent Revenue History
    • Critical Care
    • Immunoassays
    • HemoCue
    • Transcutaneous Monitoring
  • ROCHE DIAGNOSTICS
    • Key Comment
    • Recent Revenue History
    • For 2018 Compared to 2017
    • Table 14-1: Selected Roche Diagnostics Product Advances in 2018
    • Hematology
    • Core Lab
    • Immunoassays
    • Global Access Program for HIV
    • Molecular Expansion
    • Core Molecular
    • Digital PCR
    • Diabetes Care
    • Coagulation
    • cobas Liat System - POC
    • HPV
    • Blood Bank
    • Transplant Medicine
    • Cancer Companion Testing
    • Prenatal
    • Liquid Biopsy
    • IT in Anatomical Pathology
    • Information Technology
    • NimbleGen Business
    • Consulting Program
  • SIEMENS HEALTHINEERS (SIEMENS)
    • Key Comment
    • Recent Revenue History
    • Core Lab
    • Lab Automation
    • Immunoassays
    • Hematology
    • Urinalysis
    • Molecular
    • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
    • Sequencing with Artificial Intelligence
    • Zika Virus Testing
    • Acute Care - POC
    • POC Connectivity
    • Business Expansion
  • SYSMEX CORPORATION
    • Key Comment
    • Recent Revenue History
    • Hematology
    • Coagulation
    • Urinalysis
    • Immunoassays
    • Lab Information System
    • Information Technology
    • Flow Cytometry
    • Precision Medicine / Companion Test Diagnostics
    • Liquid Biopsy
    • Exosomes
    • Oncology
    • Sysmex Inostics
    • Forging New Markets
  • THERMO FISHER SCIENTIFIC INC.
    • Key Comment
    • Recent Revenue History
    • Immunoassays
    • Microbiology
    • Molecular Test Business
    • Next Generation Sequencing
    • qPCR
    • Gene Editing
    • Oncology Companion Diagnostics
    • Liquid Biopsy
    • Zika Virus
    • Transplant Medicine
    • Microbiome
    • Forensics
    • Mass Spectrometry
    • Collaborations
    • China
  • WERFEN
    • Key Comment
    • Recent Revenue History
    • Instrumentation Laboratory
    • Inova Diagnostics
    • Biokit

FIFTEEN: COMPANY PROFILES: THE SECOND TIER

  • AGILENT TECHNOLOGIES
    • Key Comment
    • Recent Revenue History
    • Agilent in Genomics
    • Cytogenetic Analysis
    • Information Technology
    • Capillary Electrophoresis
    • Sequencing
    • CRISPR
    • Flow Cytometry
    • Dako / Pathology
  • BGI GENOMICS (FORMERLY BEIJING GENOME INSTITUTE)
    • Key Comment
    • Recent Revenue History
    • MGI Tech Co., Limited, China
    • With Complete Genomics
    • Prenatal Testing
    • Test Services
    • Liquid Biopsy
    • Whole Genome Sequencing (WGS)
    • Collaborations
  • BRUKER CORPORATION
    • Key Comment
    • Recent Revenue History
    • Acquisitions and Collaborations
    • Microbiology
    • Molecular PCR
  • CEPHEID / DANAHER
    • Key Comment
    • Recent Revenue History
    • GeneXpert Xpress Line
    • High Burden Expansion
    • India
    • Tuberculosis
    • Microbiology
    • POC Testing
    • Cancer
  • EIKEN CHEMICAL CO., LTD
    • Key Comment
    • Recent Revenue History
    • Road Map Initiatives
    • Product News
  • FUJIREBIO DIAGNOSTICS, INC.
    • Key Comment
    • Recent Revenue History
    • Molecular
  • ILLUMINA
    • Key Comment
    • Recent Revenue History
    • Company Reported Highlights in 2018
    • Reported Highlights in 2016, 2017
    • Sequencing
    • Advancing in the Clinical Market
    • Sequencing Data Analysis
    • Sample Preparation
    • Microarrays
    • Project Firefly
    • Transplant Medicine
    • Liquid Biopsy
    • Forensic Medicine
    • Prenatal Testing Business
    • Collaborations
    • China
    • Investment
  • LABCORP, LABORATORY CORPORATION OF AMERICA
    • Key Comment
    • Recent Revenue History
    • LabCorp Buys Sequenom
    • Precision Medicine
    • Diagnostics Services
    • DTC Home Testing
    • Prenatal
    • Retail Services
    • Expansion
  • LEICA BIOSYSTEMS
    • Key Comment
    • Recent Revenue History
    • Digital Pathology
    • Stain Reagents
    • Lab Systems
    • Sample Handling
    • Circulating Tumor Cells (CTCs)
    • Artificial Intelligence
  • LUMINEX CORPORATION
    • Key Comment
    • Recent Revenue History
    • Assay Development
    • Verigene Business
    • PCR
    • Flow Cytometry
    • Business Expansion
  • A. MENARINI DIAGNOSTICS
    • Key Comment
    • Menarini-Silicon Biosystems Inc. (Bologna, Italy)
  • MERIDIAN BIOSCIENCE, INC.
    • Key Comment
    • Recent Revenue History
    • Immunoassays
    • Molecular Tests
    • Building U.S. and International Partnerships
    • China Businesses
  • MINDRAY - SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • Key Comment
    • Recent Revenue History
    • Core Lab
    • Hematology
  • NOVA BIOMEDICAL CORPORATION (NOVA)
    • Key Comment
    • Recent Revenue History
  • PERKINELMER, INC. (PE)
    • Key Comment
    • Recent Revenue History
    • Diagnostics
    • Sequencing /Genomics
    • Liquid Biopsy
    • Histology
    • Prenatal Business
    • Lab Services
    • Mass Spectrometry
  • PHILIPS (ROYAL PHILIPS)
    • Key Comment
    • Histology
    • Cancer Genomics
    • Precision Medicine
    • Precision Medicine IT
    • Patient Monitoring
    • Point of Care
    • Wearable Self Monitor
  • QUEST DIAGNOSTICS
    • Key Comment
    • Recent Revenue History
    • Reported Highlights
    • Diagnostic Services
    • Oncology
    • Infectious Diseases
    • Prenatal and Women's Health
    • Retail / Consumer Health
    • Expansion
  • QUIDEL CORPORATION
    • Key Comment
    • Recent Revenue History
    • Quidel Reported for 2018 . . .
    • The Alere Triage Business
    • Immunoassays
    • Rapid Immunoassays
    • The Solana Business
    • Molecular - Savanna
  • RANDOX LABORATORIES LTD.
    • Key Comment
    • Clinical Chemistries
    • Controls
    • Evidence Series - Multistat Biochip Analyzers
    • Molecular
  • VENTANA MEDICAL SYSTEMS INC. / ROCHE TISSUE DIAGNOSTICS
    • Key Comment
    • Recent Revenue History
    • Immunohistochemistry - IHC
    • Cervical Cancer Screening
    • Companion Diagnostics
    • Quality Control
    • DISCOVERY Product Line

SIXTEEN: COMPANY PROFILES: BLOOD BANK SPECIALISTS

  • BLOODSOURCE (VITALANT)
  • CERUS CORPORATION
  • HAEMOKINESIS PTY LTD
  • IMMUCOR
  • MICROTYPING CONCEPTS
  • QUOTIENT LIMITED
  • RELIANCE LIFE SCIENCES

SEVENTEEN: COMPANY PROFILES: COAGULATION SPECIALISTS

  • DIAGNOSTICA STAGO, S.A.S.
  • MICROVISK TECHNOLOGIES
  • DIAGON KFT. HUNGARY

EIGHTEEN: COMPANY PROFILES: CORE LAB AND OTHER COMPANIES

  • AB SCIEX PTE LTD.
  • EKF DIAGNOSTICS HOLDINGS PLC
  • ELITECH GROUP S.A.S.
  • ERBA DIAGNOSTICS, INC.
  • MEDTEST DX
  • MICROSAIC SYSTEMS PLC
  • NOVA BIOMEDICAL
  • SCIENION AG
  • SEKISUI DIAGNOSTICS LLC
  • SHIMADZU SCIENTIFIC INSTRUMENTS
  • SNIBE CO. LTD., (SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD.)
  • TECAN GROUP
  • TOSOH BIOSCIENCE
  • TRINITY BIOTECH PLC

NINETEEN: COMPANY PROFILES: CTC & LIQUID BIOPSY TEST PROVIDERS

  • ANGLE, PLC
  • BIOCARTIS
  • BIOCEPT, INC.
  • BIODESIX
  • CYNVENIO BIOSYSTEMS (LUNGLIFE AI)
  • EPIC SCIENCES
  • EPIGENOMICS AG
  • FOUNDATION MEDICINE, INC.
  • GENOMIC HEALTH (EXACT SCIENCES)
  • GUARDANT HEALTH, INC.
  • MENARINI-SILICON BIOSYSTEMS
  • MYRIAD GENETICS, INC.
  • NATERA
  • NEOGENOMICS

TWENTY: DIABETES SPECIALISTS

  • ANIMAS CORPORATION
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • BIGFOOT BIOMEDICAL INC.
  • CELLNOVO GROUP SA
  • DEBIOTECH SA
  • DEXCOM INC.
  • GENTAG INC.
  • GLOOKO INC.
  • GLYSURE LIMITED
  • GLYTEC LLC
  • IHEALTH LABS INC.
  • INSULET CORPORATION
  • INTEGRITY APPLICATIONS INC.
  • LIFESCAN INC.
  • MEDTRONIC PLC
  • NEMAURA MEDICAL INC.
  • NIGHTSCOUT PROJECT
  • SANOFI
  • TRIVIDIA HEALTH INC.
  • VERILY LIFE SCIENCES LLC

TWENTY-ONE: COMPANY PROFILES: HEMATOLOGY (CELL ANALYSIS) SPECIALISTS

  • CELLAVISION AB
  • HORIBA MEDICAL
  • MEDICA CORPORATION
  • ONCA XT LTD
  • WEST MEDICA

TWENTY-TWO: COMPANY PROFILES: HISTOPATHOLOGY SPECIALISTS

  • ADVANCED CELL DIAGNOSTICS (ACD)
  • AMOY DIAGNOSTICS CO. LTD.
  • APPLIED SPECTRAL IMAGING INC. (ASI)
  • BIOGENEX LABORATORIES, INC.
  • BIOVIEW LTD.
  • CIRCULOMICS INC.
  • DAKO A/S
  • DEFINIENS
  • HTG MOLECULAR DIAGNOSTICS
  • KAPA BIOSYSTEMS INC.
  • LEICA BIOSYSTEMS
  • MILLIPORESIGMA (FORMERLY EMD MILLIPORE)
  • OMNYX LLC
  • VISIOPHARM

TWENTY-THREE: COMPANY PROFILES: IMMUNOASSAY SPECIALISTS

  • BG MEDICINE, INC
  • BINDING SITE GROUP LTD. (THE)
  • BIOHIT OYJ (BIOHIT HEALTHCARE)
  • BIOMERICA INC.
  • BIO-TECHNE CORPORATION
  • CORGENIX MEDICAL CORPORATION
  • CRITICAL DIAGNOSTICS
  • EUROBIO SCIENTIFIC
  • EUROIMMUN AG
  • HOB BIOTECH
  • IMMUNODIAGNOSTIC SYSTEMS (IDS)
  • INOVA DIAGNOSTICS, INC.
  • INTEGRATED DIAGNOSTICS (NOW BIODESIX)
  • ONE LAMBDA, INC
  • ORGENTEC DIAGNOSTIKA
  • PROTAGEN DIAGNOSTICS
  • RESPONSE BIOMEDICAL CORP.
  • SINGULEX, INC.
  • THERADIG
  • VOLITIONRX LIMITED

TWENTY-FOUR: INFORMATION TECHNOLOGY SPECIALISTS IN IN VITRO DIAGNOSTICS

  • ADVAITA CORP.
  • CERNER CORP.
  • DELL TECHNOLOGIES INC.
  • DESKTOP GENETICS LTD.
  • DNANEXUS INC.
  • EDICO GENOME (ILLUMINA)
  • EUFORMATICS OY
  • GENALICE
  • GENOMONCOLOGY LLC
  • GOOGLE LLC
  • HUMAN LONGEVITY INC.
  • INTEL CORPORATION
  • INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
  • N-OF-ONE
  • PIERIANDX
  • RENNOVA HEALTH, INC.
  • SOPHIA GENETICS SA
  • SUNQUEST INFORMATION SYSTEMS INC.
  • WUXI NEXTCODE

TWENTY-FIVE: COMPANY PROFILES: MICROBIOLOGY SPECIALISTS

  • ACCELERATE DIAGNOSTICS, INC.
  • ADVANCED BIOLOGICAL LABORATORIES, S.A. (ABL)
  • ALTONA DIAGNOSTICS
  • ARCDIA INTERNATIONAL OY LTD.
  • BIOFIRE DIAGNOSTICS, LLC. (ACQUIRED BY BIOMÉRIEUX)
  • BRUKER BIOSCIENCES CORPORATION
  • COPAN ITALIA S.P.A. AND COPAN DIAGNOSTICS, INC.
  • CURETIS
  • FAST TRACK DIAGNOSTICS (ACQUIRED BY SIEMENS HEALTHINEERS)
  • FOCUS DIAGNOSTICS, INC
  • GENETIC ANALYSIS AS
  • GENEWEAVE BIOSCIENCES, INC.
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • HAIN LIFESCIENCE GMBH
  • MAST GROUP
  • MOBIDIAG LTD.
  • NANOSPHERE, INC. (LUMINEX)
  • OPGEN, INC.
  • POSITIVEID CORPORATION
  • Q-LINEA AB
  • SEEGENE, INC.
  • Recent Revenue History
  • SPECIFIC TECHNOLOGIES
  • SYNBIOSIS LTD.
  • T2 BIOSYSTEMS

TWENTY-SIX: COMPANY PROFILES: MOLECULAR TEST SPECIALISTS

  • ASURAGEN INC.
  • AUTOGENOMICS INC.
  • ENZO BIOCHEM INC.
  • EXOSOME DIAGNOSTICS, INC.
  • FLUIDIGM CORPORATION
  • GENMARK DIAGNOSTICS, INC
  • GENOME DIAGNOSTICS BV (GENDX)
  • NANOSTRING TECHNOLOGIES, INC.
  • OXFORD NANOPORE TECHNOLOGIES LTD
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACBIO)
  • QUANDX INC
  • RAINDANCE TECHNOLOGIES, INC.
  • RUBICON GENOMICS, INC.
  • TAKARA BIO INC.
  • TROVAGENE, INC.
  • VELA DIAGNOSTICS
  • WAFERGEN BIO-SYSTEMS, INC.

TWENTY-SEVEN: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS

  • ABAXIS, INC.
  • ABINGDON HEALTH LTD.
  • ATLAS GENETICS LTD. (BINX HEALTH)
  • BIOMEME, INC.
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
  • DNA ELECTRONICS LTD (DNAE)
  • ENTOPSIS
  • FABPULOUS B.V.
  • FIO CORPORATION
  • GENEDRIVE PLC (FORMERLY EPISTEM HOLDINGS)
  • HEMA DIAGNOSTIC SYSTEMS (HDS; DBA NUGENEREX DIAGNOSTICS)
  • IMMUNOSTICS, INC.
  • INSILIXA INC.
  • LOOP MEDICAL (FORMERLY QLOUDLAB SA)
  • MEDMIRA, INC.
  • ORASURE TECHNOLOGIES, INC.
  • PTS DIAGNOSTICS
  • QUANTUMDX GROUP, LTD.
  • RHEONIX, INC.
  • SAMSUNG HEALTHCARE
  • VEREDUS LABORATORIES PTE LTD

TWENTY-EIGHT: COMPANY PROFILES: PRENATAL TEST SERVICE PROVIDERS

  • AFFYMETRIX, INC.
  • BERRY GENOMICS CO. LTD.
  • COMBIMATRIX (INVITAE)
  • COOPERGENOMICS (DIVISION OF COOPERSURGICAL)
  • COUNSYL (MYRIAD WOMEN'S HEALTH)
  • GENEPEEKS, INC.
  • GENETADI BIOTECH S.L.
  • GENOMA GROUP
  • INNOVATIONS EXCHANGE PTE LTD (INEX) AND IGENE DIAGNOSTICS PTE LTD
  • LIFECODEXX AG
  • OXFORD GENE TECHNOLOGY
  • PREMAITHA HEALTH (YOURGENE HEALTH)
  • RAVGEN
  • REPRODUCTIVE GENETICS INNOVATIONS
  • SEQUENOM, INC.

TWENTY-NINE: COMPANY PROFILES: QUALITY CONTROL & SAMPLE PRETREATMENT SPECIALISTS

  • 10X GENOMICS
  • AGENA BIOSCIENCE, INC.
  • BIOTYPE DIAGNOSTIC GMBH
  • DXTERITY DIAGNOSTICS INC.
  • HORIZON DISCOVERY GROUP PLC
  • INCELLDX
  • OASIS DIAGNOSTICS CORPORATION
  • PREANALYTIX GMBH
  • PRECIPIO, INC. (FORMERLY TRANSGENOMIC)
  • QUANTERIX CORPORATION
  • SERACARE LIFE SCIENCES, INC.
  • STRECK INC.

THIRTY: TEST SERVICE PROVIDERS

  • 23ANDME
  • AGENDIA BV
  • AMBRY GENETICS
  • ARUP LABORATORIES
  • ASSUREX HEALTH
  • THE BIOCOLLECTIVE
  • BIOREFERENCE LABORATORIES
  • BIOTHERANOSTICS
  • BLUEPRINT GENETICS OY
  • BOSTON HEART DIAGNOSTICS
  • CAREDX, INC.
  • CLEVELAND HEARTLAB INC.
  • EUROFINS GENOMICS
  • EXACT SCIENCES CORP.
  • GENOMIC VISION
  • HELOMICS CORPORATION
  • MAYO MEDICAL LABORATORIES
  • MDXHEALTH SA
  • OPKO DIAGNOSTICS
  • PATHWAY GENOMICS CORPORATION
  • SONIC HEALTHCARE
  • VERACYTE, INC.
  • VERMILLION INC.
Back to Top